Hypomagnesemia and risk of post-transplant lymphoproliferative disorder in liver transplant recipients

Transpl Int. 2020 Dec;33(12):1835-1836. doi: 10.1111/tri.13735. Epub 2020 Nov 9.

Authors

Parag Mahale¹, Gregory J Mckenna², Giovanna Saracino², Linda Jennings², Sam M Mbulaiteye¹, Göran B Klintmalm², Eric A Engels¹

Affiliations

¹ Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
² Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Intramural

MeSH terms

Epstein-Barr Virus Infections*
Humans
Liver Transplantation* / adverse effects
Lymphoproliferative Disorders* / etiology
Transplant Recipients

Grants and funding